Funding for this research was provided by:
Received: 7 October 2020
Accepted: 3 November 2020
First Online: 17 November 2020
Ethics approval and consent to participate
: This study was approved under the protocol 39/18 by the Comitato Etico Indipendente, Fondazione Policlinico Tor Vergata—Rome, Italy. Informed consent was obtained from each participant involved.
: Drs. Fuciarelli and Polimanti received research grants from Pfizer Inc. to conduct epigenetic studies of hATTR. The other authors reported no biomedical financial interests or potential conflicts of interest.